- Home
- TCRX vs PFD Comparison
TCRX vs PFD Comparison
Compare TCRX & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- PFD
- Stock Information
- Founded
- TCRX 2018
- PFD 1990
- Country
- TCRX United States
- PFD United States
- Employees
- TCRX N/A
- PFD N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- PFD Investment Managers
- Sector
- TCRX Health Care
- PFD Finance
- Exchange
- TCRX Nasdaq
- PFD Nasdaq
- Market Cap
- TCRX 170.1M
- PFD 145.7M
- IPO Year
- TCRX 2021
- PFD N/A
- Fundamental
- Price
- TCRX $2.40
- PFD $11.35
- Analyst Decision
- TCRX Strong Buy
- PFD
- Analyst Count
- TCRX 5
- PFD 0
- Target Price
- TCRX $11.40
- PFD N/A
- AVG Volume (30 Days)
- TCRX 544.4K
- PFD 33.2K
- Earning Date
- TCRX 03-05-2025
- PFD 01-01-0001
- Dividend Yield
- TCRX N/A
- PFD 6.30%
- EPS Growth
- TCRX N/A
- PFD N/A
- EPS
- TCRX N/A
- PFD N/A
- Revenue
- TCRX $9,362,000.00
- PFD N/A
- Revenue This Year
- TCRX N/A
- PFD N/A
- Revenue Next Year
- TCRX $5.14
- PFD N/A
- P/E Ratio
- TCRX N/A
- PFD N/A
- Revenue Growth
- TCRX N/A
- PFD N/A
- 52 Week Low
- TCRX $2.38
- PFD $8.53
- 52 Week High
- TCRX $9.69
- PFD $11.18
- Technical
- Relative Strength Index (RSI)
- TCRX 25.27
- PFD 53.59
- Support Level
- TCRX $2.60
- PFD $11.12
- Resistance Level
- TCRX $2.85
- PFD $11.48
- Average True Range (ATR)
- TCRX 0.17
- PFD 0.19
- MACD
- TCRX 0.00
- PFD 0.02
- Stochastic Oscillator
- TCRX 2.41
- PFD 75.00
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.